Login to MyHealth
Login to My HealthThe USC Experience
Prostate cancer is the most common male malignancy after skin cancer. Patients with prostate cancer represent a dominant percentage of the oncologic practice volume at the USC Institute of Urology.
The USC Institute of Urology is a national and international leader and innovator in treatments for prostate cancer. Our team is one of only a few across the country that provides cutting-edge expertise across the entire range of prostate cancer treatments:
- Active surveillance
- Radical prostatectomy (robotic, laparoscopic, open)
- Cryotherapy
- Seed implants (bracytherapy)
- External beam radiation.
Systemic treatments with hormones, chemotherapy, and radiotherapy are also provided within our multi-disciplinary team that includes urologists, medical oncologists and radiation oncologists.
Specifically, USC urologists are acknowledged experts in robotic and laparoscopic surgery, having pioneered novel concepts for preserving potency, such as real-time intra-operative ultrasound navigation and energy-free nerve-sparing surgery, thus providing the best potency outcomes. USC urologists’ aggregate experience with robotic, laparoscopic and open radical prostatectomy exceeds 6,800 cases, making us one of the most experienced programs anywhere for prostate cancer surgery. Our cancer cure rates are among the best in the literature, with the lowest complication rates.
